IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · IEX Real-Time Price · USD
542.23
+2.66 (0.49%)
Mar 28, 2024, 12:27 PM EDT - Market open
IDEXX Laboratories Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 1995 |
---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 453.93 | 112.55 | 144.45 | 383.93 | 90.33 | 123.79 | 187.68 | 154.9 | 128.99 | 322.54 | Upgrade
|
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 284.26 | 236.95 | 213.59 | 0 | Upgrade
|
Cash & Cash Equivalents | 453.93 | 112.55 | 144.45 | 383.93 | 90.33 | 123.79 | 471.93 | 391.85 | 342.59 | 322.54 | Upgrade
|
Cash Growth | 303.33% | -22.09% | -62.37% | 325.05% | -27.04% | -73.77% | 20.44% | 14.38% | 6.22% | 15.58% | Upgrade
|
Receivables | 457.45 | 400.62 | 368.35 | 331.43 | 269.31 | 248.86 | 234.6 | 204.49 | 188.32 | 152.38 | Upgrade
|
Inventory | 380.28 | 367.82 | 269.03 | 209.87 | 195.02 | 173.3 | 164.32 | 158.03 | 188.83 | 160.34 | Upgrade
|
Other Current Assets | 203.6 | 220.49 | 173.82 | 137.51 | 124.98 | 108.22 | 101.14 | 91.21 | 101.9 | 124.14 | Upgrade
|
Total Current Assets | 1,495 | 1,101 | 955.66 | 1,063 | 679.64 | 654.17 | 971.99 | 845.58 | 821.63 | 759.4 | Upgrade
|
Property, Plant & Equipment | 817.68 | 768.09 | 692.77 | 646.34 | 614.45 | 437.27 | 379.1 | 357.42 | 333.03 | 303.59 | Upgrade
|
Goodwill and Intangibles | 450.46 | 459.47 | 458.38 | 295.89 | 298.19 | 256.31 | 243.72 | 224.38 | 234.84 | 249.57 | Upgrade
|
Other Long-Term Assets | 496.53 | 417.73 | 330.4 | 289.6 | 240.19 | 189.59 | 118.62 | 103.32 | 85.49 | 71.65 | Upgrade
|
Total Long-Term Assets | 1,765 | 1,645 | 1,482 | 1,232 | 1,153 | 883.18 | 741.43 | 685.12 | 653.36 | 624.81 | Upgrade
|
Total Assets | 3,260 | 2,747 | 2,437 | 2,295 | 1,832 | 1,537 | 1,713 | 1,531 | 1,475 | 1,384 | Upgrade
|
Accounts Payable | 110.64 | 110.22 | 116.14 | 74.56 | 72.17 | 69.53 | 66.97 | 60.06 | 52.65 | 44.74 | Upgrade
|
Deferred Revenue | 65.73 | 68.8 | 81.21 | 88.73 | 90.21 | 101.99 | 64.73 | 60.4 | 52.64 | 53.48 | Upgrade
|
Current Debt | 325 | 653.98 | 148.5 | 49.99 | 288.77 | 398.94 | 655 | 611 | 573 | 549 | Upgrade
|
Other Current Liabilities | 450.18 | 402.8 | 417.74 | 369.49 | 274.2 | 199.99 | 217.87 | 203.12 | 178.48 | 173.69 | Upgrade
|
Total Current Liabilities | 951.55 | 1,236 | 763.58 | 582.76 | 725.34 | 770.44 | 1,005 | 934.57 | 856.76 | 820.91 | Upgrade
|
Long-Term Debt | 722.55 | 795.63 | 862.58 | 935.53 | 766.38 | 601.35 | 606.08 | 593.11 | 597.09 | 350 | Upgrade
|
Other Long-Term Liabilities | 101.29 | 106.6 | 121.05 | 143.47 | 162.93 | 174.79 | 156.62 | 111.24 | 105.14 | 95.72 | Upgrade
|
Total Long-Term Liabilities | 823.85 | 902.23 | 983.63 | 1,079 | 929.31 | 776.14 | 762.69 | 704.35 | 702.23 | 445.72 | Upgrade
|
Total Liabilities | 1,775 | 2,138 | 1,747 | 1,662 | 1,655 | 1,547 | 1,767 | 1,639 | 1,559 | 1,267 | Upgrade
|
Total Debt | 1,048 | 1,450 | 1,011 | 985.52 | 1,055 | 1,000 | 1,261 | 1,204 | 1,170 | 899 | Upgrade
|
Debt Growth | -27.74% | 43.37% | 2.59% | -6.60% | 5.48% | -20.68% | 4.73% | 2.91% | 30.15% | 109.85% | Upgrade
|
Retained Earnings | 4,445 | 3,600 | 2,920 | 2,176 | 1,596 | 1,168 | 803.55 | 540.4 | 318.36 | 1,675 | Upgrade
|
Comprehensive Income | -71.21 | -77.8 | -53.48 | -53.62 | -46.18 | -41.79 | -36.47 | -43.05 | -42.27 | -8.07 | Upgrade
|
Shareholders' Equity | 1,485 | 608.74 | 689.99 | 632.09 | 177.47 | -9.51 | -54.11 | -108.35 | -84.13 | 117.52 | Upgrade
|
Net Cash / Debt | -593.62 | -1,337.06 | -866.62 | -601.59 | -964.82 | -876.49 | -789.15 | -812.26 | -827.5 | -576.46 | Upgrade
|
Net Cash Per Share | -7.07 | -15.80 | -10.01 | -6.94 | -11.02 | -9.91 | -8.81 | -8.94 | -8.84 | -5.68 | Upgrade
|
Working Capital | 543.71 | -134.33 | 192.08 | 479.98 | -45.7 | -116.27 | -32.58 | -88.98 | -35.13 | -61.51 | Upgrade
|
Book Value Per Share | 17.87 | 7.28 | 8.10 | 7.41 | 2.06 | -0.11 | -0.62 | -1.21 | -0.91 | 1.17 | Upgrade
|